Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Immuron Limited ( (AU:IMC) ) has issued an announcement.
Immuron Limited announced a proposed issue of 1,801,680 fully paid ordinary securities, with the issuance date set for January 15, 2025. This strategic move is intended to strengthen the company’s financial position and enhance its market operations, potentially impacting its industry standing and providing value to its stakeholders.
More about Immuron Limited
Immuron Limited operates in the pharmaceutical industry, focusing on the development and commercialization of oral immunotherapeutic products for the treatment of infectious diseases.
YTD Price Performance: -2.50%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €11.47M
Find detailed analytics on IMC stock on TipRanks’ Stock Analysis page.
